04 June 2026
MESA LABORATORIES INC /CO/
CIK: 724004•3 Annual Reports•Latest: 2026-06-03
Disclaimer: AI-assisted summary of SEC Form 10-K filings. Not official company content and not investment, legal, accounting, or tax advice. See full disclaimer here.
10-K / June 3, 2026
Revenue:$249,130,000
Income:$6,712,000
10-K / May 28, 2025
Revenue:$241,000,000
Income:-$1,974,000
10-K / June 28, 2024
Revenue:$216,187,000
Income:-$254,246,000
10-K / June 3, 2026
Mesa Laboratories, Inc.
Company and scope
- Legal name: Mesa Laboratories, Inc., a Colorado corporation
- Fiscal year end: March 31
- Headquarters: Lakewood, Colorado
- Primary business: Global design and manufacture of life sciences tools and critical quality-control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries
- Markets and sales:
- Manufacturing operations in the United States and Europe
- Products sold by direct sales in North America, Europe, and the Asia Pacific region (APAC), and through independent distributors worldwide
- Nasdaq ticker: MLAB
Employees (as of March 31, 2026)
- Total: 717
- Manufacturing and quality assurance: 347
- Research and development and engineering: 99
- Sales and marketing: 179
- Administrative functions: 92
Business metrics and geography
- Non-U.S. operations:
- About 8% of fiscal 2026 sales were from China
- About 45% of fiscal 2026 sales were from other non-U.S. countries, primarily Europe
- Backlog (firm orders to be fulfilled within 12 months):
- March 31, 2026: $33.6 million
- March 31, 2025: $43.2 million
- The company realized higher revenues and higher adjusted operating income (a non-GAAP measure) in fiscal 2026 versus the prior year
- Customer concentration:
- No single customer accounted for more than 10% of consolidated revenues in fiscal 2026
- In the Clinical Genomics division, one customer accounted for approximately 20% of that division’s revenues in fiscal 2026
Segments
1) Sterilization and Disinfection Control (SDC)
- Focus: Biological indicators, chemical indicators, and cleaning indicators for assessing sterilization, decontamination, disinfection, and cleaning processes; sterility assurance testing and laboratory services (primarily dental and pharmaceutical customers)
- Products and formats:
- Biological indicators: inoculated carriers (spore strips/discs), self-contained indicators with growth media, process challenge devices (PCDs)
- Chemical indicators: color-change indicators for sterilization parameter exposure
- Cleaning indicators: simulants for washer and ultrasonic cleaner performance
- Growth media and related testing services
- Manufacturing locations: Bozeman, Montana; Waldems, Germany; Munich, Germany
- Brands/products produced: GKE Clean-Record indicators, Apex biological indicators, EZTest self-contained indicators, and PCDs
- Acquisition: GKE GmbH, SAL GmbH, and GKE China were acquired (GKE GmbH/SAL completed October 2023; GKE China completed December 31, 2023) for total consideration of $87.187 million (net of cash and liabilities, including working capital adjustments); $9.555 million was paid in April 2025 to settle the portion held back for indemnification
- Regulatory: Pursuing 510(k) clearance for certain GKE products in the U.S.
2) Biopharmaceutical Development
- Focus: Automated systems for protein analysis (immunoassays) and peptide synthesis solutions, plus service and support contracts
- Capabilities:
- Protein analysis (immunoassays) to detect and quantify proteins for therapy development and bioprocess workflows
- Automated peptide synthesis for longer and complex peptides used in therapeutics and research
- Key products and platforms:
- Gyrolab xPand and Gyrolab xPlore hardware/software, Gyrolab Bioaffy consumable disks, Gyrolab kits, Rexxip buffers (developed/manufactured in Uppsala, Sweden)
- PurePep Symphony and Chorus instruments (developed/manufactured in Tucson, Arizona)
- Production locations: Sweden (products shipped internationally; costs in Swedish krona) and Tucson, Arizona
- Revenue mix (fiscal 2026):
- About 35% from consumables (routine purchases)
- About 40% from hardware purchases (more discretionary)
- Remainder from service and support agreements
- Sales channels: Direct sales and independent foreign distributors
3) Calibration Solutions
- Focus: Quality-control products that use metrology to calibrate critical parameters for renal care, gas/air flow, environmental/process monitoring, and torque testing
- Product families:
- Calibration instruments for gas/air flow and environmental/process monitoring (data loggers)
- Torque-testing systems
- Renal care meters for dialysis machine calibration and consumable calibration solutions for dialysis clinics
- Continuous monitoring systems: wireless sensors for temperature, humidity, pressure and differential pressure with cloud or local-server data transmission, alarms, and notifications
- Manufacturing: Lakewood, Colorado and Hanover, Germany
- Applications: Quality control and regulatory compliance across pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental settings
4) Clinical Genomics
- Focus: High-throughput genetic analysis instruments, consumables, and related services for clinical research labs and CROs
- Core platform: MassARRAY system (mass spectrometry with end-point PCR) enabling multiplexed genetic analysis
- Consumables: Chips, panels, and reagent solutions; consumables account for approximately 80% of division revenues (hardware sales are more cyclical)
- Services: Maintenance contracts and customized laboratory services
- Production: Instruments and consumables manufactured in San Diego, California
- Customers and channels: Direct sales and independent distributors; customers include clinical research labs, contract research organizations, specialty/reference/pathology labs, academic, hospital, and government facilities
Other business context
- Strategy and operating approach: Organic growth, targeted acquisitions, and continuous efficiency improvements through the Mesa Way — a lean-based improvement system with pillars: Measure what matters, Empower Teams, Sustainably Improve, Always Learn
- Intellectual property and regulatory: Portfolio of patents and trademarks; compliance with ISO standards and FDA requirements integrated into manufacturing and product development
- Corporate responsibility and human capital: Emphasis on an inclusive workforce, employee engagement, total rewards, health and safety, governance, and data privacy and cybersecurity governance
- Facilities and properties: Owned facilities in Lakewood (Calibration Solutions) and Bozeman (SDC); multiple leased facilities in Germany, Sweden, and the United States supporting the company’s divisions
